Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies.
Saved in:
| Title: | Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies. |
|---|---|
| Authors: | He, Yonghan1 (AUTHOR), Khan, Sajid1 (AUTHOR), Huo, Zhiguang2 (AUTHOR), Lv, Dongwen1 (AUTHOR), Zhang, Xuan3 (AUTHOR), Liu, Xingui1 (AUTHOR), Yuan, Yaxia1 (AUTHOR), Hromas, Robert4 (AUTHOR), Xu, Mingjiang5 (AUTHOR), Zheng, Guangrong3 (AUTHOR), Zhou, Daohong1 (AUTHOR) zhoudaohong@cop.ufl.edu |
| Source: | Journal of Hematology & Oncology. 7/27/2020, Vol. 13 Issue 1, p1-24. 24p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
